FindTrial
Sign In

Definitive Radiochemotherapy

RADIATION3 trials

Sponsors

Tianjin Medical University Cancer Institute and Hospital

Conditions

Stage II Esophageal CancerStage III Esophageal CancerUnresectable Esophageal Cancer

Phase 2

A Phase II Trial to Compare Efficacy and Safety of CRT VS Neo-CRT in Patients Who Achieved CCR for Esophageal Cancer
NCT02959385
Tianjin Medical University Cancer Institute and HospitalStage II Esophageal Cancer, Stage III Esophageal Cancer
Start: 2016-09-30End: 2021-09-30Target: 40Updated: 2017-07-18
Efficacy and Safety of Neo-CRT Followed Surgery Compared With Definitive CRT in Patients With Initial Unresectable ESO
NCT04137679
Tianjin Medical University Cancer Institute and HospitalUnresectable Esophageal Cancer
Start: 2019-11-01End: 2022-08-31Target: 60Updated: 2019-11-01

Phase 3

A Study to Compare Efficacy and Safety of DRT VS CRT Plus Surgery in Patients Who Achieved CCR for Esophageal Cancer
NCT03708042
Tianjin Medical University Cancer Institute and HospitalStage II Esophageal Cancer, Stage III Esophageal Cancer
Start: 2018-12-01End: 2023-12-01Target: 220Updated: 2018-10-16

Related Papers

CCL4 and MIF: Prognostic Biomarkers for Evaluating the Chemoradiotherapy Response and Prognosis in Patients with ESCC
Journal of Cancer2025-03-03
Role of clip markers placed by endoscopic ultrasonography in contouring gross tumor volume for thoracic esophageal squamous cell carcinoma: one prospective study.
2020-09-012 citations